Xconomy’s Digital Events →
The pieces are in place for Facebook’s IPO next week—not only has the company set its stock price range and updated its Q1 numbers, it has also attempted to de-risk... Read more »
From Our Partners · Special Report
Advice for funding and future transformational opportunities
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.